Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 10 EP applications Mathilde Rauline has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 14, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12305415

Use of an h3 receptor antagonist for the treatment of alzheimer's disease

IPC classification:
A61K 31/4725, A61P 25/00
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION REFUSED
EP11731176

SUBSTITUTED N-PHENYL SPIROLACTAM BIPYRROLIDINES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/403, A61P 25/00, C07D 401/10, C07D 403/10
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731171

SUBSTITUTED N-ALKYL AND N-ACYL TETRAHYDRO-ISOQUINOLINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/4709, A61P 25/00, C07D 401/14, C07D 403/04, C07D 407/14, C07D 495/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731172

Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof

IPC classification:
A61K 31/407, A61K 31/438, A61K 31/4439, A61P 25/16, A61P 25/18, A61P 25/24, A61P 25/28, C07D 401/14, C07D 471/10, C07D 491/107
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11306170

Bi-aryl derivatives, their preparation and their therapeutic application

IPC classification:
A61K 31/196, A61K 31/216, A61P 27/06, C07C 217/84
Applicant:
Fovea Pharmaceuticals SA
Agent:
Claude Jacobson, Cabinet Lavoix
Agent:
Mathilde Rauline, Fovea Pharmaceuticals SA
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12305130

2-(3-aminophenoxy)-acetic acid derivatives as EP2 receptor agonists for use in treatment of glaucoma

IPC classification:
A61K 31/196, A61P 27/02, C07C 217/84
Applicant:
Fovea Pharmaceuticals SA
Agent:
Claude Jacobson, Cabinet Lavoix
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731175

SUBSTITUTED N-HETEROCYCLOALKYL BIPYRROLIDINYLPHENYL AMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/351, A61K 31/4439, A61P 25/00, C07D 401/12, C07D 405/12
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11731173

Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof

IPC classification:
A61K 31/40, A61K 31/403, A61K 31/407, A61K 31/438, A61K 31/453, A61K 31/4535, A61K 31/454, C07D 207/06, C07D 401/12, C07D 403/10, C07D 405/12, C07D 409/12, C07D 413/12, C07D 471/10, C07D 491/107
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Mathilde Rauline, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11731174

SUBSTITUTED N-HETEROARYL TETRAHYDRO-ISOQUINOLINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/4709, A61P 25/00, C07D 401/14, C07D 403/14, C07D 413/14
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11725830

SUBSTITUTED N-HETEROARYL BIPYRROLIDINE CARBOXAMIDES, PREPARATION AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/4427, A61P 37/08, C07D 401/04, C07D 403/14
Applicant:
Sanofi, S.A.
Agent:
Mathilde Rauline, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature